Drug Shortage Report for GRAVOL IM
Report ID | 111339 |
Drug Identification Number | 00013579 |
Brand name | GRAVOL IM |
Common or Proper name | DIMENHYDRINATE INJECTION |
Company Name | CHURCH & DWIGHT CANADA CORP |
Market Status | MARKETED |
Active Ingredient(s) | DIMENHYDRINATE |
Strength(s) | 50MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAMUSCULAR |
Packaging size | 10 X 1 mL |
ATC code | R06AA |
ATC description | ANTIHISTAMINES FOR SYSTEMIC USE |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | |
Actual start date | 2020-10-09 |
Estimated end date | 2020-12-22 |
Actual end date | 2020-12-22 |
Shortage status | Resolved |
Updated date | 2021-08-16 |
Company comments | Due to the current situation (Covid-19) we are not able to pull forward any production. Therefore we can no longer meet demand of any of our clients. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 635 SECRETARIAT COURT MISSISSAUGA, ONTARIO CANADA L5S 0A5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2020-04-07 | English | Compare |
v2 | 2020-04-07 | English | Compare |
v3 | 2020-04-07 | English | Compare |
v4 | 2020-04-07 | French | Compare |
v5 | 2020-10-16 | English | Compare |
v6 | 2020-10-16 | English | Compare |
v7 | 2020-10-16 | French | Compare |
v8 | 2021-08-16 | English | Compare |
v9 | 2021-08-16 | French | Compare |
Showing 1 to 9 of 9